{"title":"Rate Versus Rhythm Control for Atrial Fibrillation with Heart Failure","authors":"Sanjeev Saksena MBBS, MD, FHRS, FESC, FRSM , April Slee PhD","doi":"10.1016/j.ccep.2024.09.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39250,"journal":{"name":"Cardiac Electrophysiology Clinics","volume":"17 1","pages":"Pages 19-41"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiac Electrophysiology Clinics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877918224000571","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
心房颤动合并心力衰竭的速率与节律控制。
房颤合并心力衰竭是一种主要的心血管疾病,其中心衰是房颤最常见的并发症。从机制上讲,这两种情况都会促进心房和心室的底物病变。房颤是心衰进展和泵衰竭死亡的独立危险因素。虽然早期比较心律控制抗心律失常药物和心率控制药物的研究显示,在心血管结局方面没有显著的益处,但房颤确实促进了心衰的发生和住院。新的心律控制策略与目前的抗心律失常药物和导管消融支持心房颤动合并心衰的心血管结局。导管消融改善了射血分数降低的HF患者的HF预后,但需要进一步和更大规模的研究,特别是对于射血分数保留的AF合并HF患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。